Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia.

Frei CR, Restrepo MI, Mortensen EM, Burgess DS.

Am J Med. 2006 Oct;119(10):865-71.

PMID:
17000218
2.
3.

Evidence-based emergency medicine/critically appraised topic. Evidence behind the 4-hour rule for initiation of antibiotic therapy in community-acquired pneumonia.

Yu KT, Wyer PC.

Ann Emerg Med. 2008 May;51(5):651-62, 662.e1-2. doi: 10.1016/j.annemergmed.2007.10.022. Epub 2008 Feb 13. Review.

PMID:
18272253
4.

Adherence to guidelines for community-acquired pneumonia: does it decrease cost of care?

Brown PD.

Pharmacoeconomics. 2004;22(7):413-20. Review.

PMID:
15137880
5.

Impact of guidelines on outcome: the evidence.

Martínez R, Reyes S, Lorenzo MJ, Menéndez R.

Semin Respir Crit Care Med. 2009 Apr;30(2):172-8. doi: 10.1055/s-0029-1202936. Epub 2009 Mar 18. Review.

PMID:
19296417
6.

Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis.

Asadi L, Sligl WI, Eurich DT, Colmers IN, Tjosvold L, Marrie TJ, Majumdar SR.

Clin Infect Dis. 2012 Aug;55(3):371-80. doi: 10.1093/cid/cis414. Epub 2012 Apr 16. Review.

PMID:
22511553
7.

Community-acquired pneumonia: process of care studies.

Metersky ML.

Curr Opin Infect Dis. 2002 Apr;15(2):169-74. Review.

PMID:
11964919
8.

Community-acquired pneumonia in adults: initial antibiotic therapy.

King DE, Pippin HJ Jr.

Am Fam Physician. 1997 Aug;56(2):544-50. Review.

PMID:
9262534
9.

The impact of guidelines on the outcomes of community-acquired and ventilator-associated pneumonia.

Ferrer M, Menendez R, Amaro R, Torres A.

Clin Chest Med. 2011 Sep;32(3):491-505. doi: 10.1016/j.ccm.2011.06.002. Review.

PMID:
21867818
10.

Guideline-concordant antimicrobial therapy for healthcare-associated pneumonia: a systematic review and meta-analysis.

Troitino AX, Porhomayon J, El-Solh AA.

Lung. 2013 Jun;191(3):229-37. doi: 10.1007/s00408-013-9462-8. Epub 2013 Apr 10. Review.

PMID:
23572322
11.

Treatment guidelines and outcomes of hospital-acquired and ventilator-associated pneumonia.

Torres A, Ferrer M, Badia JR.

Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S48-53. doi: 10.1086/653049. Review. Erratum in: Clin Infect Dis. 2010 Nov 1;51(9):1114.

PMID:
20597672
12.

[Optimizing the antibiotics policy in The Netherlands. VIII. Revised SWAB guidelines for antimicrobial therapy in adults with community-acquired pneumonia].

Schouten JA, Prins JM, Bonten M, Degener JE, Janknegt R, Hollander JM, Jonkers R, Wijnands W, Verheij T, Sachs A, Kullberg BJ.

Ned Tijdschr Geneeskd. 2005 Nov 5;149(45):2495-500. Review. Dutch.

PMID:
16304886
13.
14.

[Patients hospitalized with community-acquired pneumonia: a comparative study of outcomes by medical specialty area].

Capelastegui A, España PP, Quintana JM, Gorordo I, Martínez Urquiri A, Idoiaga I, Bilbao A.

Arch Bronconeumol. 2005 Jun;41(6):300-6. Review. Spanish.

15.

Administration of first hospital antibiotics for community-acquired pneumonia: does timeliness affect outcomes?

Houck PM, Bratzler DW.

Curr Opin Infect Dis. 2005 Apr;18(2):151-6. Review.

PMID:
15735420
16.

Review of treatment guidelines for community-acquired pneumonia.

Niederman MS.

Am J Med. 2004 Aug 2;117 Suppl 3A:51S-57S. Review.

PMID:
15360097
17.

Achieving a safe and early discharge for patients with community-acquired pneumonia.

Rhew DC, Weingarten SR.

Med Clin North Am. 2001 Nov;85(6):1427-40. Review.

PMID:
11686189
18.

Severe community-acquired pneumonia.

Alvarez-Lerma F, Torres A.

Curr Opin Crit Care. 2004 Oct;10(5):369-74. Review.

PMID:
15385753
19.

Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia.

Brito V, Niederman MS.

Curr Opin Infect Dis. 2009 Jun;22(3):316-25. doi: 10.1097/QCO.0b013e328329fa4e. Review.

PMID:
19352176
20.

Nursing home-acquired pneumonia: update on treatment options.

Mylotte JM.

Drugs Aging. 2006;23(5):377-90. Review.

PMID:
16823991

Supplemental Content

Support Center